Epigenetics and atherosclerosis

Biochimica et Biophysica Acta - General Subjects

Volumn 1790, Issue 9, 2009, Pages 886-891

  Turunen, Mikko P ^a   Aavik, Einari ^b   Ylä Herttuala, Seppo ^b,c  

^a Finland Ark Therapeutics Oy   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Atherosclerosis; Epigenetic; Histone code; Homocysteinemia; Hypercholesterolemia; Methylation

Indexed keywords

ARACHIDONATE 15 LIPOXYGENASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENOMIC DNA; HISTONE; HISTONE H3; HISTONE LYSINE DEMETHYLASE 1; MICRORNA; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; UNCLASSIFIED ENZYME;

ATHEROGENESIS; ATHEROSCLEROSIS; AUTOIMMUNITY; CARDIOVASCULAR RISK; CELL PROLIFERATION; DNA HYPERMETHYLATION; DNA HYPOMETHYLATION; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION REGULATION; GENETIC REGULATION; HISTONE CODE; HISTONE MODIFICATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERHOMOCYSTEINEMIA; INCIDENCE; INFLAMMATION; ISCHEMIC HEART DISEASE; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN METHYLATION; PROTEIN MODIFICATION; REVIEW; RNA INTERFERENCE; SMOOTH MUSCLE FIBER;

ANIMALS; ATHEROSCLEROSIS; DNA METHYLATION; EPIGENESIS, GENETIC; HISTONES; HUMANS; HYPERHOMOCYSTEINEMIA;

EID: 68349099021     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2009.02.008     Document Type: Review

References (83)

1. Matouk C.C., and Marsden P.A. Epigenetic regulation of vascular endothelial gene expression. Circ. Res. 102 (2008) 873
2. Rose G. Familial patterns in ischaemic heart disease. Br. J. Prev. Soc. Med. 18 75-80 (1964) 75
3. Barker D.J. Fetal programming of coronary heart disease. Trends Endocrinol. Metab. 13 (2002) 364
4. Alkemade F.E., Gittenberger-de Groot A.C., Schiel A.E., VanMunsteren J.C., Hogers B., van Vliet L.S., Poelmann R.E., Havekes L.M., Willems van D.K., and DeRuiter M.C. Intrauterine exposure to maternal atherosclerotic risk factors increases the susceptibility to atherosclerosis in adult life. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 2228
5. Lehmann R., Denes R., Nienhaus R., Steinbach T., Lusztig G., and Sanatger R.M. Alteration of chromatin in early experimental arteriosclerosis. Artery 8 (1980) 288
6. Lamon B.D., and Hajjar D.P. Inflammation at the molecular interface of atherogenesis: an anthropological journey. Am. J. Pathol. 173 (2008) 1253
7. Ylä-Herttuala S., Palinski W., Rosenfeld M.E., Parthasarathy S., Carew T.E., Butler S., Witztum J.L., and Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84 (1989) 1086
8. Wissler R.W. Update on the pathogenesis of atherosclerosis. Am. J. Med. 91 (1991) 3S
9. Sanchez L.A., and Veith F.J. Diagnosis and treatment of chronic lower extremity ischemia. Vasc. Med. 3 (1998) 291
10. Lusis A.J. Atherosclerosis. Nature 407 (2000) 233
11. Ross R. Mechanisms of disease - atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340 (1999) 115
12. Laukkanen M.O., Mannermaa S., Hiltunen M.O., Aittomaki S., Airenne K., Janne J., and Yla-Herttuala S. Local hypomethylation in atherosclerosis found in rabbit ec-sod gene. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 2171
13. Hiltunen M.O., and Yla-Herttuala S. DNA methylation, smooth muscle cells, and atherogenesis. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 1750
14. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352 (2005) 1685
15. Napoli C., Glass C.K., Witztum J.L., Deutsch R., D'Armiento F.P., and Palinski W. Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) study. Lancet. 354 (1999) 1234
16. Napoli C., Witztum J.L., Calara F., de Nigris F., and Palinski W. Maternal hypercholesterolemia enhances atherogenesis in normocholesterolemic rabbits, which is inhibited by antioxidant or lipid-lowering intervention during pregnancy: an experimental model of atherogenic mechanisms in human fetuses. Circ. Res. 87 (2000) 946
17. Napoli C., de N.F., Welch J.S., Calara F.B., Stuart R.O., Glass C.K., and Palinski W. Maternal hypercholesterolemia during pregnancy promotes early atherogenesis in LDL receptor-deficient mice and alters aortic gene expression determined by microarray. Circulation 19 105 (2002) 1360
18. Madsen C., gnaes-Hansen F., Moller J., and Falk E. Hypercholesterolemia in pregnant mice does not affect atherosclerosis in adult offspring. Atherosclerosis 168 (2003) 221
19. Dobosy J.R., Fu V.X., Desotelle J.A., Srinivasan R., Kenowski M.L., Almassi N., Weindruch R., Svaren J., and Jarrard D.F. A methyl-deficient diet modifies histone methylation and alters Igf2 and H19 repression in the prostate. Prostate 68 (2008) 1187
20. Kono S., and Chen K. Genetic polymorphisms of methylenetetrahydrofolate reductase and colorectal cancer and adenoma. Cancer Sci. 96 (2005) 535
21. Amor D.J., and Halliday J. A review of known imprinting syndromes and their association with assisted reproduction technologies. Hum. Reprod. 23 (2008) 2826
22. Weaver I.C., Champagne F.A., Brown S.E., Dymov S., Sharma S., Meaney M.J., and Szyf M. Reversal of maternal programming of stress responses in adult offspring through methyl supplementation: altering epigenetic marking later in life. J. Neurosci. 25 (2005) 11045
23. Boushey C.J., Beresford S.A., Omenn G.S., and Motulsky A.G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274 (1995) 1049
24. Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 288 (2002) 2015
25. Castro R., Rivera I., Struys E.A., Jansen E.E., Ravasco P., Camilo M.E., Blom H.J., Jakobs C., and Tavares d.A. I, Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease. Clin. Chem. 49 (2003) 1292
26. Lee M.E., and Wang H. Homocysteine and hypomethylation. A novel link to vascular disease. Trends Cardiovasc. Med. 9 (1999) 49
27. James S.J., Melnyk S., Pogribna M., Pogribny I.P., and Caudill M.A. Elevation in S-adenosylhomocysteine and DNA hypomethylation: potential epigenetic mechanism for homocysteine-related pathology. J. Nutr. 132 (2002) 2361S
28. Chang P.Y., Lu S.C., Lee C.M., Chen Y.J., Dugan T.A., Huang W.H., Chang S.F., Liao W.S., Chen C.H., and Lee Y.T. Homocysteine inhibits arterial endothelial cell growth through transcriptional downregulation of fibroblast growth factor-2 involving G protein and DNA methylation. Circ. Res. 102 (2008) 933
29. Sharma P., Senthilkumar R.D., Brahmachari V., Sundaramoorthy E., Mahajan A., Sharma A., and Sengupta S. Mining literature for a comprehensive pathway analysis: a case study for retrieval of homocysteine related genes for genetic and epigenetic studies. Lipids Health Dis. 5 1 (2006) 1
30. Ehrlich M., Gama-Sosa M.A., Huang L.H., Midgett R.M., Kuo K.C., McCune R.A., and Gehrke C. Amount and distribution of 5-methylcytosine in human DNA from different types of tissues of cells. Nucleic Acids Res. 10 (1982) 2709
31. Hiltunen M.O., Turunen M.P., Hakkinen T.P., Rutanen J., Hedman M., Makinen K., Turunen A.M., alto-Setala K., and Yla-Herttuala S. DNA hypomethylation and methyltransferase expression in atherosclerotic lesions. Vasc. Med. 7 (2002) 5
32. Miranda T.B., and Jones P.A. DNA methylation: the nuts and bolts of repression. J. Cell Physiol. 213 (2007) 384
33. Fuks F., Hurd P.J., Deplus R., and Kouzarides T. The DNA methyltransferases associate with HP1 and the SUV39H1 histone methyltransferase. Nucleic Acids Res. 31 (2003) 2305
34. Villeneuve L.M., Reddy M.A., Lanting L.L., Wang M., Meng L., and Natarajan R. Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 9047
35. Shen L., Kondo Y., Guo Y., Zhang J., Zhang L., Ahmed S., Shu J., Chen X., Waterland R.A., and Issa J.P. Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promoters. PLoS. Genet. 3 (2007) 2023
36. Collas P., Noer A., and Timoskainen S. Programming the genome in embryonic and somatic stem cells. J. Cell Mol. Med. 11 (2007) 602
37. Bannister A.J., and Kouzarides T. Reversing histone methylation. Nature 436 (2005) 1103
38. Weaver I.C., Meaney M.J., and Szyf M. Maternal care effects on the hippocampal transcriptome and anxiety-mediated behaviors in the offspring that are reversible in adulthood. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 3480
39. Post W.S., Goldschmidt-Clermont P.J., Wilhide C.C., Heldman A.W., Sussman M.S., Ouyang P., Milliken E.E., and Issa J.P. Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovasc. Res. 43 (1999) 985
40. Chan G.C., Fish J.E., Mawji I.A., Leung D.D., Rachlis A.C., and Marsden P.A. Epigenetic basis for the transcriptional hyporesponsiveness of the human inducible nitric oxide synthase gene in vascular endothelial cells. J. Immunol. 175 (2005) 3846
41. Fish J.E., Matouk C.C., Rachlis A., Lin S., Tai S.C., D'Abreo C., and Marsden P.A. The expression of endothelial nitric-oxide synthase is controlled by a cell-specific histone code. J. Biol. Chem. 280 (2005) 24824
42. Luoma J.S., Strålin P., Marklund S.L., Hiltunen T.P., Särkioja T., and Ylä-Herttuala S. Expression of extracellular SOD and iNOS in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesions - colocalization with epitopes characteristic of oxidized LDL and peroxynitrite-modified proteins. Arterioscler. Thromb. Vasc. Biol. 18 (1998) 157
43. Wilcox J.N., Subramanian R.R., Sundell C.L., Tracey W.R., Pollock J.S., Harrison D.G., and Marsden P.A. Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels. Arterioscler. Thromb. Vasc. Biol. 17 (1997) 2479
44. Wenger R.H., Kvietikova I., Rolfs A., Camenisch G., and Gassmann M. Oxygen-regulated erythropoietin gene expression is dependent on a CpG methylation-free hypoxia-inducible factor-1 DNA-binding site. Eur. J. Biochem. 253 (1998) 771
45. Perini G., Diolaiti D., Porro A., and Della V.G. In vivo transcriptional regulation of N-Myc target genes is controlled by E-box methylation. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 12117
46. Bell A.C., and Felsenfeld G. Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene. Nature 405 (2000) 482
47. Defossez P.A., Kelly K.F., Filion G.J., Perez-Torrado R., Magdinier F., Menoni H., Nordgaard C.L., Daniel J.M., and Gilson E. The human enhancer blocker CTC-binding factor interacts with the transcription factor Kaiso. J. Biol. Chem. 280 (2005) 43017
48. Sharma P., Kumar J., Garg G., Kumar A., Patowary A., Karthikeyan G., Ramakrishnan L., Brahmachari V., and Sengupta S. Detection of altered global DNA methylation in coronary artery disease patients. DNA Cell Biol. 27 (2008) 357
49. Castro R., Rivera I., Blom H.J., Jakobs C., and Tavares d.A. I, Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: an overview. J. Inherit. Metab. Dis. 29 (2006) 3
50. Jiang Y., Zhang J., Xiong J., Cao J., Li G., and Wang S. Ligands of peroxisome proliferator-activated receptor inhibit homocysteine-induced DNA methylation of inducible nitric oxide synthase gene. Acta Biochim. Biophys. Sin. (Shanghai) 39 (2007) 366
51. Ying A.K., Hassanain H.H., Roos C.M., Smiraglia D.J., Issa J.J., Michler R.E., Caligiuri M., Plass C., and Goldschmidt-Clermont P.J. Methylation of the estrogen receptor-alpha gene promoter is selectively increased in proliferating human aortic smooth muscle cells. Cardiovasc. Res. 46 (2000) 172
52. Kim J., Kim J.Y., Song K.S., Lee Y.H., Seo J.S., Jelinek J., Goldschmidt-Clermont P.J., and Issa J.P. Epigenetic changes in estrogen receptor beta gene in atherosclerotic cardiovascular tissues and in-vitro vascular senescence. Biochim. Biophys. Acta 1772 (2007) 72
53. Issa J.P. CpG-island methylation in aging and cancer. Curr. Top. Microbiol. Immunol. 249 101-18 (2000) 101
54. Liu C., Xu D., Sjoberg J., Forsell P., Bjorkholm M., and Claesson H.E. Transcriptional regulation of 15-lipoxygenase expression by promoter methylation. Exp. Cell Res. 297 (2004) 61
55. Stenvinkel P., Karimi M., Johansson S., Axelsson J., Suliman M., Lindholm B., Heimburger O., Barany P., Alvestrand A., Nordfors L., Qureshi A.R., Ekstrom T.J., and Schalling M. Impact of inflammation on epigenetic DNA methylation - a novel risk factor for cardiovascular disease?. J. Intern. Med. 261 (2007) 488
56. Wilson V.L., and Jones P.A. DNA methylation decreases in aging but not in immortal cells. Science 220 (1983) 1055
57. Butcher L.M., and Beck S. Future impact of integrated high-throughput methylome analyses on human health and disease. J. Genet. Genomics. 35 (2008) 391
58. Shimabukuro M., Sasaki T., Imamura A., Tsujita T., Fuke C., Umekage T., Tochigi M., Hiramatsu K., Miyazaki T., Oda T., Sugimoto J., Jinno Y., and Okazaki Y. Global hypomethylation of peripheral leukocyte DNA in male patients with schizophrenia: a potential link between epigenetics and schizophrenia. J. Psychiatr. Res. 41 (2007) 1042
59. Lund G., Andersson L., Lauria M., Lindholm M., Fraga M.F., Villar-Garea A., Ballestar E., Esteller M., and Zaina S. DNA methylation polymorphisms precede any histological sign of atherosclerosis in mice lacking apolipoprotein E. J. Biol. Chem. 279 (2004) 29147
60. Voo K.S., Carlone D.L., Jacobsen B.M., Flodin A., and Skalnik D.G. Cloning of a mammalian transcriptional activator that binds unmethylated CpG motifs and shares a CXXC domain with DNA methyltransferase, human trithorax, and methyl-CpG binding domain protein 1. Mol. Cell. Biol. 20 (2000) 2108
61. Ansari K.I., Mishra B.P., and Mandal S.S. Human CpG binding protein interacts with MLL1, MLL2 and hSet1 and regulates Hox gene expression. Biochim. Biophys. Acta 1779 (2008) 66
62. Roman-Gomez J., Jimenez-Velasco A., Agirre X., Cervantes F., Sanchez J., Garate L., Barrios M., Castillejo J.A., Navarro G., Colomer D., Prosper F., Heiniger A., and Torres A. Promoter hypomethylation of the LINE-1 retrotransposable elements activates sense/antisense transcription and marks the progression of chronic myeloid leukemia. Oncogene 24 (2005) 7213
63. Ylä-Herttuala S., Palinski W., Butler S.W., Picard S., Steinberg D., and Witztum J.L. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler. Thromb. 14 (1994) 32
64. Richardson B.C. Role of DNA methylation in the regulation of cell function: autoimmunity, aging and cancer. J. Nutr. 132 (2002) 2401S
65. Choi J.H., Nam K.H., Kim J., Baek M.W., Park J.E., Park H.Y., Kwon H.J., Kwon O.S., Kim D.Y., and Oh G.T. Trichostatin A exacerbates atherosclerosis in low density lipoprotein receptor-deficient mice. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 2404
66. Reddy M.A., Villeneuve L.M., Wang M., Lanting L., and Natarajan R. Role of the lysine-specific demethylase 1 in the proinflammatory phenotype of vascular smooth muscle cells of diabetic mice. Circ. Res. (2008)
67. Lan F., Nottke A.C., and Shi Y. Mechanisms involved in the regulation of histone lysine demethylases. Curr. Opin. Cell Biol. 20 (2008) 316
68. Benditt E.P., and Benditt J.M. Evidence for a monoclonal origin of human atherosclerotic plaques. Proc. Natl. Acad. Sci. U. S. A. 70 (1973) 1753
69. Mette M.F., Aufsatz W., van der W.J., Matzke M.A., and Matzke A.J. Transcriptional silencing and promoter methylation triggered by double-stranded RNA. EMBO J. 19 (2000) 5194
70. Weinberg M.S., Villeneuve L.M., Ehsani A., Amarzguioui M., Aagaard L., Chen Z.X., Riggs A.D., Rossi J.J., and Morris K.V. The antisense strand of small interfering RNAs directs histone methylation and transcriptional gene silencing in human cells. RNA 12 (2006) 256
71. Morris K.V., Chan S.W., Jacobsen S.E., and Looney D.J. Small interfering RNA-induced transcriptional gene silencing in human cells. Science 305 (2004) 1289
72. Kim D.H., Saetrom P., Snove Jr. O., and Rossi J.J. MicroRNA-directed transcriptional gene silencing in mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 16230
73. Chan Y., Fish J.E., D'Abreo C., Lin S., Robb G.B., Teichert A.M., Karantzoulis-Fegaras F., Keightley A., Steer B.M., and Marsden P.A. The cell-specific expression of endothelial nitric-oxide synthase: a role for DNA methylation. J. Biol. Chem. 279 (2004) 35087
74. Devlin A.M., Singh R., Wade R.E., Innis S.M., Bottiglieri T., and Lentz S.R. Hypermethylation of Fads2 and altered hepatic fatty acid and phospholipid metabolism in mice with hyperhomocysteinemia. J. Biol. Chem. 282 (2007) 37082
75. Hastings N.E., Simmers M.B., McDonald O.G., Wamhoff B.R., and Blackman B.R. Atherosclerosis-prone hemodynamics differentially regulates endothelial and smooth muscle cell phenotypes and promotes pro-inflammatory priming. Am. J. Physiol. Cell Physiol. 293 (2007) C1824-C1833
76. Geisel J., Schorr H., Heine G.H., Bodis M., Hubner U., Knapp J.P., and Herrmann W. Decreased p66Shc promoter methylation in patients with end-stage renal disease. Clin. Chem. Lab. Med. 45 (2007) 1764
77. Devlin A.M., Bottiglieri T., Domann F.E., and Lentz S.R. Tissue-specific changes in H19 methylation and expression in mice with hyperhomocysteinemia. J. Biol. Chem. 280 (2005) 25506
78. Sato N., Maehara N., Su G.H., and Goggins M. Effects of 5-aza-2′-deoxycytidine on matrix metalloproteinase expression and pancreatic cancer cell invasiveness. J. Natl. Cancer Inst. 19 95 (2003) 327
79. Wild A., Ramaswamy A., Langer P., Celik I., Fendrich V., Chaloupka B., Simon B., and Bartsch D.K. Frequent methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene in pancreatic endocrine tumors. J. Clin. Endocrinol. Metab. 88 (2003) 1367
80. White G.P., Watt P.M., Holt B.J., and Holt P.G. Differential patterns of methylation of the IFN-gamma promoter at CpG and non-CpG sites underlie differences in IFN-gamma gene expression between human neonatal and adult CD45RO- T cells. J. Immunol. 168 (2002) 2820
81. Lin X.H., Guo C., Gu L.J., and Deuel T.F. Site-specific methylation inhibits transcriptional activity of platelet-derived growth factor A-chain promoter. J. Biol. Chem. 268 (1993) 17334
82. Tanaka Y., Fukudome K., Hayashi M., Takagi S., and Yoshie O. Induction of ICAM-1 and LFA-3 by Tax1 of human T-cell leukemia virus type 1 and mechanism of down-regulation of ICAM-1 or LFA-1 in adult-T-cell-leukemia cell lines. Int. J. Cancer. 60 (1995) 554
83. Schroeder M., and Mass M.J. CpG methylation inactivates the transcriptional activity of the promoter of the human p53 tumor suppressor gene. Biochem. Biophys. Res. Commun. 235 (1997) 403